Obstructive Sleep Apnea
Conditions
Keywords
Sleep apnea diagnosis, Sleep apnea monitoring
Brief summary
This prospective study aims to evaluate a new medical screening method to detect and discriminate sleep apnea-hypopnea events. A new device called ApneaBand will be tested to propose a new screening method facilitating the diagnosis and monitoring of the sleep apnea syndrom, still underdiagnosed. This device will be tested in comparison with polysomnography (PSG), the gold standard reference method of sleep apnea diagnosis.
Detailed description
The objective of this study is to dertermine the performance of the ApneaBand, a new non-intrusive and portable device, in detecting sleep apnea, in comparison with PSG. 40 apneic and non apneic subjects will wear the ApneaBand recording the different sleep stages and the occurency of apnea-hypopnea sleep events through four sensors including oximetry (oxygen saturation), photoplethysmography (pulse wave), electrodermal activity and tri-axial accelerometer (movements). Inclusion visit will be proceeded at the University Hospital Grenoble-Alpes ; polysomnography and mesures by the ApneaBand will be proceeded at the patient's home by IC@dom. Patients will be equiped with PSG + ApneaBand during the first night and with ApneaBand only the second night.
Interventions
DEVICEApneaBand
Mesure of oxygen saturation (oximetry), pulse wave (photoplethysmography), electrodermal activity and movements (tri-axial accelerometer)
Sponsors
Commissariat A L'energie Atomique
AIRFAN
AGIR à Dom
University Hospital, Grenoble
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients with moderate or severe obstructive sleep apnea (OSA), diagnosed by polygraphy or PSG for less than 2 years, and not treated for that. * Non apneic person (Berlin score = 0 or 1) * Person be able to use the personal health monitoring device ApneaBand * Be legally able to give consent * Person affiliated to social security
Exclusion criteria
* Patient already treated for OSA * Patient equipped with an electric medical device (non-exhaustive examples: cardiac pace maker, cochlear implant, neuro-stimulator) * Being unable to understand and to follow recommendations for the study due to cognition or language problems * Pregnant women, feeding and parturient * Person under administrative or judicial control, or who is protected under the act * Person in exclusion period for another study * Person which would perceive more than 4500 euros of compensation because of its participation in other clinical studies in 12 months preceding this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Performance of the ApneaBand to detect sleep apnea | 3 days | Performance of the ApneaBand device in detecting moderate to severe sleep apnea (defined by an Apnea-Hypopnea Index (AHI) ≥ 15 events/hour), in comparison with PSG |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| External reproductibility of AHI measurement by the ApneaBand | 3 days | Reproducibility between AHI from polysomnography and ApneaBand |
| Internal reproductibility of AHI measurement by the ApneaBand | 3 days | Reproducibility between different AHI mesures from ApneaBand |
| Performance of the ApneaBand to mesure the apnea severity | 3 days | Performance of the ApneaBand device in detecting sleep apnea according to its severity (2 pre-specified thresholds of AHI: \> 5 and ≥ 30), in comparison with PSG |
| Sleep stage detection by ApneaBand | 3 days | To assess if electrodermal activity assessed by the ApneaBand during sleep is able to differerenciate the different sleep stages |
| Skin tone variability | 3 days | To asses if oxygen saturation assessed by the ApneaBand could be performed in persons with dark skin tones |
| ApneaBand algorith validation for AHI measurement | 3 days | External validation of the ApneaBand algorithm |
Countries
France
Outcome results
None listed